BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 33816292)

  • 21. Theaflavin-3, 3'-digallate induces apoptosis and G2 cell cycle arrest through the Akt/MDM2/p53 pathway in cisplatin-resistant ovarian cancer A2780/CP70 cells.
    Tu Y; Kim E; Gao Y; Rankin GO; Li B; Chen YC
    Int J Oncol; 2016 Jun; 48(6):2657-65. PubMed ID: 27082635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Daphnetin triggers ROS-induced cell death and induces cytoprotective autophagy by modulating the AMPK/Akt/mTOR pathway in ovarian cancer.
    Fan X; Xie M; Zhao F; Li J; Fan C; Zheng H; Wei Z; Ci X; Zhang S
    Phytomedicine; 2021 Feb; 82():153465. PubMed ID: 33486268
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circadian Clock Protein PERIOD2 Suppresses the PI3K/Akt Pathway and Promotes Cisplatin Sensitivity in Ovarian Cancer.
    Wang Z; Li F; Wei M; Zhang S; Wang T
    Cancer Manag Res; 2020; 12():11897-11908. PubMed ID: 33244267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interference with the expression of β-catenin reverses cisplatin resistance in A2780/DDP cells and inhibits the progression of ovarian cancer in mouse model.
    Zhao H; Wei W; Sun Y; Gao J; Wang Q; Zheng J
    DNA Cell Biol; 2015 Jan; 34(1):55-62. PubMed ID: 25211326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Noscapine Increases the Sensitivity of Drug-Resistant Ovarian Cancer Cell Line SKOV3/DDP to Cisplatin by Regulating Cell Cycle and Activating Apoptotic Pathways.
    Shen W; Liang B; Yin J; Li X; Cheng J
    Cell Biochem Biophys; 2015 May; 72(1):203-13. PubMed ID: 25510462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Forkhead Box Protein C2 Promotes Epithelial-Mesenchymal Transition, Migration and Invasion in Cisplatin-Resistant Human Ovarian Cancer Cell Line (SKOV3/CDDP).
    Li C; Ding H; Tian J; Wu L; Wang Y; Xing Y; Chen M
    Cell Physiol Biochem; 2016; 39(3):1098-110. PubMed ID: 27562816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Combined inhibition of PI3K and MEK has synergistic inhibitory effect on the proliferation of cisplatin-resistant ovarian cancer cells].
    Liu Y; Chen X; Luo Z
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jun; 30(6):592-6. PubMed ID: 24909280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chloroquine reverses chemoresistance via upregulation of p21
    Hwang JR; Kim WY; Cho YJ; Ryu JY; Choi JJ; Jeong SY; Kim MS; Kim JH; Paik ES; Lee YY; Han HD; Lee JW
    Cell Death Dis; 2020 Dec; 11(12):1034. PubMed ID: 33277461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reprogramming of glutamine metabolism via glutamine synthetase silencing induces cisplatin resistance in A2780 ovarian cancer cells.
    Guo J; Satoh K; Tabata S; Mori M; Tomita M; Soga T
    BMC Cancer; 2021 Feb; 21(1):174. PubMed ID: 33596851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase pathway overcomes cisplatin resistance in ovarian carcinoma cells.
    Nonaka M; Itamochi H; Kawaguchi W; Kudoh A; Sato S; Uegaki K; Naniwa J; Sato S; Shimada M; Oishi T; Terakawa N; Kigawa J; Harada T
    Int J Gynecol Cancer; 2012 Jul; 22(6):922-9. PubMed ID: 22672985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of ALDH1A1-NEK-2 axis in cisplatin resistance in ovarian cancer cells.
    Uddin MH; Kim B; Cho U; Azmi AS; Song YS
    Heliyon; 2020 Nov; 6(11):e05442. PubMed ID: 33241139
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Downregulation of ATG14 by EGR1-MIR152 sensitizes ovarian cancer cells to cisplatin-induced apoptosis by inhibiting cyto-protective autophagy.
    He J; Yu JJ; Xu Q; Wang L; Zheng JZ; Liu LZ; Jiang BH
    Autophagy; 2015; 11(2):373-84. PubMed ID: 25650716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endoplasmic reticulum stress promotes autophagy and apoptosis and reverses chemoresistance in human ovarian cancer cells.
    Hu JL; Hu XL; Guo AY; Wang CJ; Wen YY; Cang SD
    Oncotarget; 2017 Jul; 8(30):49380-49394. PubMed ID: 28537902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ATP citrate lyase mediates resistance of colorectal cancer cells to SN38.
    Zhou Y; Bollu LR; Tozzi F; Ye X; Bhattacharya R; Gao G; Dupre E; Xia L; Lu J; Fan F; Bellister S; Ellis LM; Weihua Z
    Mol Cancer Ther; 2013 Dec; 12(12):2782-91. PubMed ID: 24132143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ATP citrate lyase: activation and therapeutic implications in non-small cell lung cancer.
    Migita T; Narita T; Nomura K; Miyagi E; Inazuka F; Matsuura M; Ushijima M; Mashima T; Seimiya H; Satoh Y; Okumura S; Nakagawa K; Ishikawa Y
    Cancer Res; 2008 Oct; 68(20):8547-54. PubMed ID: 18922930
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Restoration of microRNA-708 sensitizes ovarian cancer cells to cisplatin via IGF2BP1/Akt pathway.
    Qin X; Sun L; Wang J
    Cell Biol Int; 2017 Oct; 41(10):1110-1118. PubMed ID: 28685895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cordycepin enhances the chemosensitivity of esophageal cancer cells to cisplatin by inducing the activation of AMPK and suppressing the AKT signaling pathway.
    Gao Y; Chen DL; Zhou M; Zheng ZS; He MF; Huang S; Liao XZ; Zhang JX
    Cell Death Dis; 2020 Oct; 11(10):866. PubMed ID: 33067427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The PI3K/AKT/mTOR pathway is a potential predictor of distinct invasive and migratory capacities in human ovarian cancer cell lines.
    Bai H; Li H; Li W; Gui T; Yang J; Cao D; Shen K
    Oncotarget; 2015 Sep; 6(28):25520-32. PubMed ID: 26267321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Over-expression of PTEN sensitizes human ovarian cancer cells to cisplatin-induced apoptosis in a p53-dependent manner.
    Yan X; Fraser M; Qiu Q; Tsang BK
    Gynecol Oncol; 2006 Aug; 102(2):348-55. PubMed ID: 16545436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Knockdown of MALAT1 enhances chemosensitivity of ovarian cancer cells to cisplatin through inhibiting the Notch1 signaling pathway.
    Bai L; Wang A; Zhang Y; Xu X; Zhang X
    Exp Cell Res; 2018 May; 366(2):161-171. PubMed ID: 29548748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.